Advances in the Diagnosis and Treatment of BPDCN

Video

Related Videos
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD
Sundar Jagannath, MBBS
Nikhil Gopal, MD, assistant professor, urology, College of Medicine, Memphis Department of Urology, The University of Tennessee Health Science Center
Ashwin Kishtagari, MD
Somedeb Ball, MBBS
Lauren E. Nye, MD
Jonathan E. Rosenberg, MD
Related Content
Updates and Advances in Early Stage Breast Cancer

Updates and Advances in Early Stage Breast Cancer

April 5th 2023
Article
Manali Kamdar, MD

Dr. Kamdar on the Results of the TRANSFORM Trial in Relapsed/Refractory LBCL

December 11th 2021
Article
Brandon Blue, MD

Dr. Blue on the Utility of Carfilzomib in Relapsed/Refractory Multiple Myeloma

October 1st 2021
Article
Randall Shares How Postoperative Radiotherapy Retains a Role in Soft Tissue Sarcoma

Randall Shares How Postoperative Radiotherapy Retains a Role in Soft Tissue Sarcoma

July 29th 2020
Article
Dr. Jacobson on the Benefit of Axi-Cel in Relapsed/Refractory Follicular Lymphoma

Dr. Jacobson on the Benefit of Axi-Cel in Relapsed/Refractory Follicular Lymphoma

June 11th 2020
Article
Dr. Katz on Determining Low-Risk Disease in Prostate Cancer

Dr. Katz on Determining Low-Risk Disease in Prostate Cancer

June 2nd 2020
Article